Results 21 to 30 of about 7,115 (197)

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study [PDF]

, 2016
Background: Serious inhaler technique errors can impair drug delivery to the lungs. This randomised, crossover, open-label study evaluated the proportion of patients making predefined serious errors with Pulmojet compared with Diskus and Turbohaler dry ...
A Palander, A Papi, Anne Burden, AS Melani, BL Laube, Catherine Hutton, D Price, D Price, D Price, D Price, David B. Price, Dawn Shan, E Mehuys, Erika Sims, F Lavorini, F Yildiz, Federico Lavorini, GK Crompton, GN Rootmensen, H Al-Jahdali, H Chrystyn, Henry Chrystyn, IA Basheti, J Haughney, J Haughney, J Palen van der, J Steier, JC McElnay, JC Virchow, JL Rau, John Efthimiou, John Haughney, KG Nielsen, L Borgstrom, M Molimard, M Molimard, M Moller, M Schulte, MA Crane, Mathieu Molimard, MS Blaiss, Nicolas Roche, PN Dekhuijzen, RA Al-Showair, S Verver, Sinthia Bosnic-Anticevich, SP Newman, SZ Bosnic-Anticevich, V Giraud, V Giraud, V Giraud, W Azouz, Y Aydemir   +52 more
core   +2 more sources

Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma.

International journal of clinical practice, 2007
Budesonide/formoterol is an effective treatment for both asthma and chronic obstructive pulmonary disease. This study compared the efficacy and safety of a novel hydrofluoroalkane (HFA) pressurised metered-dose inhaler (pMDI) formulation of budesonide/formoterol with that of budesonide pMDI and budesonide/formoterol dry-powder inhaler (DPI; Turbuhaler).
Morice, A H, Peterson, S, Beckman, O, Osmanliev, D   +3 more
openaire   +3 more sources

Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs

Respiratory Medicine, 2000
Fluticasone propionate pressurized metered dose inhalers (pMDIs) containing the hydrofluoroalkane (HFA) propellant, HFA 134a, are being developed to replace existing chlorofluorocarbon (CFC) pMDIs. This is part of the ongoing worldwide project to limit the damage to the earth's ozone layer.The in vivo performance and dose proportionality of fluticasone
Kunka, R., Andrews, S., Pimazzoni, M., Callejas, S., Ziviani, L, Squassante, L., Daley-Yates, P.T.   +6 more
openaire   +2 more sources

The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation [PDF]

, 2002
Background: This review examines the clinical effectiveness and cost-effectiveness of hand-held inhalers to deliver medication for the routine management of chronic asthma in children aged between 5 and 15 years.
Beverley, C., Lim, J.N.W., Peters, J., Smith, S., Stevenson, M.   +4 more
core   +1 more source

Rapid interrogation of the physical and chemical characteristics of salbutamol sulphate aerosol from a pressurised metered-dose inhaler (pMDI) [PDF]

, 2014
Individual micron-sized solid particles from a Salamols pharmaceutical inhaler are stably captured in air using an optical trap for the first time. Raman spectroscopy of the levitated particles allows online interrogation of composition and deliquescent ...
A. D. Ward, Aggarwal, Ali, Balani, Bell, Broday, C. Fitzgerald, Dodson, Dunbar, F. D. Pope, H.-J. Tong, Haddrell, King, Knox, Labiris, Lakowicz, Lavorini, M. K. Kuimova, M. Kalberer, Mao, P. C. Seville, P. J. Gallimore, Pandya, Peterman, Rkiouak, Tang, Taylor, Wang   +27 more
core   +2 more sources

Evaluation of proficiency in using different inhaler devices among intern doctors

Journal of Family Medicine and Primary Care, 2016
Context: Doctors may have deficiencies in the ability to use different inhalers, which in turn, can result in improper technique by the patients and poorly controlled asthma and chronic obstructive pulmonary disease (COPD).
Ravish M Kshatriya, Nimit V Khara, Rajiv P Paliwal, Satish N Patel   +3 more
doaj   +1 more source

How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze [PDF]

, 2015
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in ...
Dekhuijzen, Richard, Gappa, Monika, Garcia-Marcos, Luis, Lenney, Warren, Pedersen, Søren, Price, David, van Aalderen, Wim M   +6 more
core   +5 more sources

Clinical outcomes of children using a metered dose inhaler with a sleeve attachment device to improve ease of use

Journal of Allergy and Clinical Immunology: Global, 2023
Background: Activating pressurized metered dose inhalers (pMDIs) is often challenging for children. The Easy Squeezy (ES) is a novel sleeve attachment device that reduces activation force by 3 times.
Kassim Babu Mapondela, MD, MMed (ENT), Roopam Dey, PhD, Michael Levin, MBChB, PhD   +2 more
doaj   +1 more source

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]

, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Cates, CJ, Jaeschke, R, Lasserson, TJ
core   +1 more source

Patients' perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler® [PDF]

, 2016
Poor inhaler technique hampers the efficacy of drug therapy in asthma and chronic obstructive pulmonary disease. Not only does this affect individual patient care, but it also impacts on the wider health care economics associated with these conditions ...
Dekhuijzen, PNR, Lavorini, F, Usmani, OS
core   +7 more sources